Page 1698 - Hematology_ Basic Principles and Practice ( PDFDrive )

1512.e4 Part VIII Comprehensive Care of Patients with Hematologic Malignancies

130. Ortin TT, Shostak CA, Donaldson SS: Gonadal status and reproduc- 151. Mattano LA, Jr, Sather HN, Trigg ME, et al: Osteonecrosis as a com-
tive function following treatment for Hodgkin’s disease in childhood: plication of treating acute lymphoblastic leukemia in children: a report
the Stanford experience. Int J Radiat Oncol Biol Phys 19(4):873–880, from the Children’s Cancer Group. J Clin Oncol 18(18):3262–3272,
1990. 2000.
131. Green DM, Brecher ML, Lindsay AN, et al: Gonadal function in 152. Strauss AJ, Su JT, Dalton VM, et al: Bony morbidity in children treated
pediatric patients following treatment for Hodgkin disease. Med Pediatr for acute lymphoblastic leukemia. J Clin Oncol 19(12):3066–3072,
Oncol 9(3):235–244, 1981. 2001.
132. Chapman RM, Sutcliffe SB, Malpas JS: Cytotoxic-induced ovarian 153. Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, et al: Osteo-
failure in women with Hodgkin’s disease. I. Hormone function. JAMA necrosis in adult survivors of childhood cancer: a report from the
242(17):1877–1881, 1979. childhood cancer survivor study. J Clin Oncol 26(18):3038–3045,
133. Green DM, Sklar CA, Boice JD, Jr, et al: Ovarian failure and repro- 2008.
ductive outcomes after childhood cancer treatment: results from the 154. Enright H, Haake R, Weisdorf D: Avascular necrosis of bone: a common
Childhood Cancer Survivor Study. J Clin Oncol 27(14):2374–2381, serious complication of allogeneic bone marrow transplantation. Am J
2009. Med 89(6):733–738, 1990.
134. Viviani S, Santoro A, Ragni G, et al: Gonadal toxicity after combination 155. Socie G, Selimi F, Sedel L, et al: Avascular necrosis of bone after
chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs allogeneic bone marrow transplantation: clinical findings, incidence
ABVD. Eur J Cancer Clin Oncol 21(5):601–605, 1985. and risk factors. Br J Haematol 86(3):624–628, 1994.
135. Green DM, Liu W, Kutteh WH, et al: Cumulative alkylating agent 156. Socie G, Cahn JY, Carmelo J, et al: Avascular necrosis of bone after
exposure and semen parameters in adult survivors of childhood allogeneic bone marrow transplantation: analysis of risk factors for
cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM).
15(11):1215–1223, 2014. Br J Haematol 97(4):865–870, 1997.
136. Hobbie WL, Ginsberg JP, Ogle SK, et al: Fertility in males treated 157. Li X, Brazauskas R, Wang Z, et al: Avascular necrosis of bone after allo-
for Hodgkins disease with COPP/ABV hybrid. Pediatr Blood Cancer geneic hematopoietic cell transplantation in children and adolescents.
44(2):193–196, 2005. Biol Blood Marrow Transplant 20(4):587–592, 2014.
137. Green DM, Kawashima T, Stovall M, et al: Fertility of male survivors of 158. Campbell S, Sun CL, Kurian S, et al: Predictors of avascular necrosis
childhood cancer: a report from the Childhood Cancer Survivor Study. of bone in long-term survivors of hematopoietic cell transplantation.
J Clin Oncol 28(2):332–339, 2010. Cancer 115(18):4127–4135, 2009.
138. Sanders JE: The impact of marrow transplant preparative regimens on 159. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al: Osteopenia
subsequent growth and development. The Seattle Marrow Transplant in young adult survivors of childhood cancer. Med Pediatr Oncol
Team. Semin Hematol 28(3):244–249, 1991. 32(4):272–278, 1999.
139. Rovo A, Tichelli A, Passweg JR, et al: Spermatogenesis in long-term 160. Redman JR, Bajorunas DR, Wong G, et al: Bone mineralization in
survivors after allogeneic hematopoietic stem cell transplantation is women following successful treatment of Hodgkin’s disease. Am J Med
associated with age, time interval since transplantation, and apparently 85(1):65–72, 1988.
absence of chronic GvHD. Blood 108(3):1100–1105, 2006. 161. Holmes SJ, Whitehouse RW, Clark ST, et al: Reduced bone mineral
140. Byrne J, Fears TR, Gail MH, et al: Early menopause in long-term survi- density in men following chemotherapy for Hodgkin’s disease. Br J
vors of cancer during adolescence. Am J Obstet Gynecol 166(3):788–793, Cancer 70(2):371–375, 1994.
1992. 162. Kaste SC, Rai SN, Fleming K, et al: Changes in bone mineral density
141. Afify Z, Shaw PJ, Clavano-Harding A, et al: Growth and endocrine in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood
function in children with acute myeloid leukaemia after bone marrow Cancer 46(1):77–87, 2006.
transplantation using busulfan/cyclophosphamide. Bone Marrow Trans- 163. Jarfelt M, Fors H, Lannering B, et al: Bone mineral density and bone
plant 25(10):1087–1092, 2000. turnover in young adult survivors of childhood acute lymphoblastic
142. Sanders JE, Hawley J, Levy W, et al: Pregnancies following high-dose leukaemia. Eur J Endocrinol 154(2):303–309, 2006.
cyclophosphamide with or without high-dose busulfan or total-body 164. Moleski M: Neuropsychological, neuroanatomical, and neurophysi-
irradiation and bone marrow transplantation. Blood 87(7):3045–3052, ological consequences of CNS chemotherapy for acute lymphoblastic
1996. leukemia. Arch Clin Neuropsychol 15(7):603–630, 2000.
143. Kenney LB, Cohen LE, Shnorhavorian M, et al: Male reproductive 165. Ochs J, Mulhern R, Fairclough D, et al: Comparison of neuropsycho-
health after childhood, adolescent, and young adult cancers: a report logic functioning and clinical indicators of neurotoxicity in long-term
from the Children’s Oncology Group. J Clin Oncol 30(27):3408–3416, survivors of childhood leukemia given cranial radiation or parenteral
2012. methotrexate: a prospective study. J Clin Oncol 9(1):145–151,
144. Metzger ML, Meacham LR, Patterson B, et al: Female reproductive 1991.
health after childhood, adolescent, and young adult cancers: guidelines 166. Butler RW, Haser JK: Neurocognitive effects of treatment for childhood
for the assessment and management of female reproductive complica- cancer. Ment Retard Dev Disabil Res Rev 12(3):184–191, 2006.
tions. J Clin Oncol 31(9):1239–1247, 2013. 167. Campbell LK, Scaduto M, Sharp W, et al: A meta-analysis of the
145. Blatt J: Pregnancy outcome in long-term survivors of childhood cancer. neurocognitive sequelae of treatment for childhood acute lymphocytic
Med Pediatr Oncol 33(1):29–33, 1999. leukemia. Pediatr Blood Cancer 49(1):65–73, 2007.
146. Signorello LB, Mulvihill JJ, Green DM, et al: Congenital anomalies in 168. Peterson CC, Johnson CE, Ramirez LY, et al: A meta-analysis of the
the children of cancer survivors: a report from the childhood cancer neuropsychological sequelae of chemotherapy-only treatment for pedi-
survivor study. J Clin Oncol 30(3):239–245, 2012. atric acute lymphoblastic leukemia. Pediatr Blood Cancer 51(1):99–104,
147. Kenney LB, Nicholson HS, Brasseux C, et al: Birth defects in offspring 2008.
of adult survivors of childhood acute lymphoblastic leukemia. A 169. Kadan-Lottick NS, Brouwers P, Breiger D, et al: Comparison of
Childrens Cancer Group/National Institutes of Health Report. Cancer neurocognitive functioning in children previously randomly assigned
78(1):169–176, 1996. to intrathecal methotrexate compared with triple intrathecal therapy for
148. Winther JF, Olsen JH, Wu H, et al: Genetic disease in the children the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol
of Danish survivors of childhood and adolescent cancer. J Clin Oncol 27(35):5986–5992, 2009.
30(1):27–33, 2012. 170. Conklin HM, Krull KR, Reddick WE, et al: Cognitive outcomes follow-
149. Assouline-Dayan Y, Chang C, Greenspan A, et al: Pathogenesis and ing contemporary treatment without cranial irradiation for childhood
natural history of osteonecrosis. Semin Arthritis Rheum 32(2):94–124, acute lymphoblastic leukemia. J Natl Cancer Inst 104(18):1386–1395,
2002. 2012.
150. Lafforgue P: Pathophysiology and natural history of avascular necrosis 171. Iyer NS, Balsamo LM, Bracken MB, et al: Chemotherapy-only treat-
of bone. Joint Bone Spine 73(5):500–507, 2006. ment effects on long-term neurocognitive functioning in childhood